Form D · Pharmaceuticals
MARINUS PHARMACEUTICALS, INC.
Radnor, PA · CIK 0001267813
Offering snapshot reported Apr 4, 2022 · SEC filing
- Reported sold
- $1.23M Offering amount: $1.23M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 29, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 4, 2022 | Initial | $1,230,085 | No comparison | 1 | SEC filing |
| Dec 19, 2019 | Initial | $30,000,000 | No comparison | 4 | SEC filing |
| Jul 9, 2013 | Amendment | $21,772,848 | $10,337,158vs Dec 18, 2012 | 7 | SEC filing |
| Dec 18, 2012 | Initial | $11,435,690 | No comparison | 6 | SEC filing |
| Apr 22, 2009 | Initial | $20,411,559 | No comparison | Not reported | SEC filing |
| Oct 12, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 2, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-440156
Source: Form D, filed Apr 4, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Santiago Arroyo, M.D., Ph.D. | Director |
| Charles Austin | Director |
| Alan Barber | Executive |
| Stephen Bloch | Director |
| Stephen Bloch, M.D. | Director |
| Scott Braunstein, Md | Director, Executive |
| Scott Braunstein, M.D. | Director, Executive |
| Enrique J. Carrazana, Md | Director |
| Christopher M. Cashman | Director, Executive |
| Michael R. Dougherty | Director |
| Elan Ezickson | Director |
| Seth H.Z. Fischer | Director |
| Anton Gopka | Director |
| Joe Hulihan, Md | Executive |
| Joseph Hulihan, M.D. | Executive |
| John Krayacich | Director, Executive |
| Martha Manning, Esq. | Executive |
| Tim M. Mayleben | Director |
| Timothy M. Mayleben | Director |
| Anand Mehra | Director |
| Anand Mehra, M.D. | Director |
| Saraswathy Nochur, Ph.D. | Director |
| Harry Penner | Director |
| Harry H. Penner, Jr. | Director |
| Steven E. Pfanstiel | Executive |
| Harry T. Rein | Director |
| Kenneth Shaw | Executive |
| Edward F. Smith | Executive |
| Cable Stuart | Executive |
| Nicole Vitullo | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
5 Radnor Corporate Center, Suite 500 100 Matsonford Road
Radnor, PA, 19087
Radnor, PA, 19087